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Tau is a multiply phosphorylated protein that is essential for
the development andmaintenance of thenervous system. Errors
in Tau action are associated with Alzheimer disease and related
dementias. A huge literature has led to the widely held notion
that aberrant Tau hyperphosphorylation is central to these dis-
orders. Unfortunately, our mechanistic understanding of the
functional effects of combinatorial Tau phosphorylation
remains minimal. Here, we generated four singly pseudophos-
phorylated Tau proteins (at Thr231, Ser262, Ser396, and Ser404)
and four doubly pseudophosphorylated Tau proteins using the
same sites. Each Tau preparation was assayed for its abilities to
promote microtubule assembly and to regulate microtubule
dynamic instability in vitro. All four singly pseudophosphory-
lated Tau proteins exhibited loss-of-function effects. Inmarked
contrast to the expectation that doubly pseudophosphorylated
Tau would be less functional than either of its corresponding
singly pseudophosphorylated forms, all of the doubly pseudo-
phosphorylated Tau proteins possessed enhanced microtubule
assembly activity and were more potent at regulating dynamic
instability than their compromised singly pseudophosphory-
lated counterparts. Thus, the effects of multiple pseudophos-
phorylations were not simply the sum of the effects of the
constituent single pseudophosphorylations; rather, they were
generally opposite to the effects of singly pseudophosphorylated
Tau. Further, despite being pseudophosphorylated at different
sites, the four singly pseduophosphorylated Tau proteins often
functioned similarly, as did the four doubly pseudophosphory-
lated proteins. These data lead us to reassess the conventional
view of combinatorial phosphorylation in normal and patholog-
ical Tau action. Theymay also be relevant to the issue of combi-
natorial phosphorylation as a general regulatory mechanism.
The neural microtubule-associated protein Tau is critical for
promoting neuronal cell polarity and axonal outgrowth during
development as well as maintaining axonal morphology and
function in mature cells (1–4). On the other hand, abnormal
Tau behavior has long been associated with Alzheimer disease
and related dementias (5, 6).
Mechanistically, Tau binds directly to microtubules, pro-
motes microtubule assembly, and regulates microtubule
dynamic instability (7–15). Indeed, proper regulation of the
growing and shortening dynamics of microtubules is essential
for many cellular functions, including neuronal axonal trans-
port (16–20). Further, misregulation of microtubule dynamic
instability can lead to cell cycle arrest followed by cell death in
dividing cells (21, 22).
Given the importance of properly regulating microtubule
dynamic instability, it is not surprising that a regulator of
microtubule dynamic instability such as Tau is itself tightly reg-
ulated. Indeed, Tau action is regulated by both alternative RNA
splicing (23, 24) and phosphorylation (25). Alternative splicing
generates sixCNSTau isoforms, each possessing either three or
four imperfect repeats in the C terminus, separated from one
another by shorter interrepeats (Fig. 1). This region of repeats
and interrepeats harbors inherent microtubule binding activity
(12–14, 26, 27) and is capable of regulating microtubule
dynamic instability (9, 11, 14, 27–30). Importantly, whereas
fetal human brain expresses only three-repeat (3R)2 Tau, adult
human brain expresses approximately equal amounts of four-
repeat (4R) and 3R Tau (28, 31). With respect to phosphoryla-
tion, normal adult Tau possesses an average of 2–3 phos-
phates/molecule, whereas fetal Tau possesses an average of
6–7 phosphates/molecule (32–34). Remarkably, phosphory-
lation can occur at 30 different amino acid positions in Tau
(35–38). It follows that the potential structural and functional
complexity of Tau is enormous. Unfortunately, our mechanis-
tic and functional understanding of combinatorial Tau phos-
phorylation remains extremely limited.
Among the most prominent pathologies of Alzheimer dis-
ease and related dementias are neurofibrillary tangles, abnor-
mal intracellular aggregates composed primarily of hyper-
phosphorylated Tau (39–41). Indeed, Tau phosphorylation
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is increased 3–4-fold in Alzheimer disease brain compared
with normal adult human brain (33, 34, 42). These observations
have led to a long-standing andwidely accepted hypothesis that
abnormal Tau hyperphosphorylation is a key step in the
Alzheimer disease pathway (25, 43). This notion has been sup-
ported by numerous cell culture and transgenic Tau models
(44–51).
Genetic analyses in 1998 (52–55) demonstrated that muta-
tions in the Tau gene were linked to frontal-temporal dementia
with Parkinsonism linked to chromosome 17 (FTDP-17) aswell
as progressive supranuclear palsy and cortico-basal degenera-
tion. More specifically, molecular analyses demonstrated that
errors in Tau action, caused by either structural alterations of
Tau or misregulation of Tau RNA splicing can cause neuronal
cell death and dementia. Because phosphorylation is a major
mechanism regulating Tau action, it follows that aberrant Tau
phosphorylation could also have catastrophic consequences.
Unfortunately, the precise molecular mechanisms by which
Taumediates neuronal cell death remain elusive. A widely held
“gain of toxic function” model suggests that abnormal Tau
phosphorylation increases its propensity to form abnormal Tau
fibers, which are proposed to be cytotoxic. However, it has been
shown thatTau-dependent neurodegeneration can occur in the
absence of Tau aggregates in some model systems and in cul-
ture (48, 51, 56–58), suggesting that Tau aggregatesmay not be
necessary for Tau-mediated cell death. A more recent gain-of-
function model suggests that small Tau oligomers might be
toxic (59). Alternatively, a loss-of-function “misregulation of
microtubule dynamics” model suggests that mutation and/or
abnormal phosphorylation of Taumight compromise its ability
to regulate microtubule dynamic instability, which in turn
causes cell death and subsequent dementia (10, 11, 60–62).
This model is based on extrapolation from pharmacological
and somatic cell genetics studies in dividing cells (21, 22).
Despite the paucity of work assessing the functional and
mechanistic effects of combinatorial Tau phosphorylation
(which is the state of both normal and pathological Tau), it has
nonetheless become widely held that the combinatorial effects
of multiple phosphorylation events within individual Tau mol-
ecules are simply the sum of the effects of the constituent single
phosphorylation events, which have generally been observed to
diminish Tau activities. However, basic protein biochemistry
raises the possibility that this may be too simple a point of view.
In an attempt to better understand the regulatory and mecha-
nistic effects of multiple versus single phosphorylation events
upon protein action, focusing on Tau, we have methodically
examined the effects of pseudophosphorylation of Tau at four
key phosphorylation sites (Thr231, Ser262, Ser396, and Ser404),
individually and combinatorially, upon the abilities of Tau (i) to
bind and assemble microtubules and (ii) to regulate microtu-
bule dynamic instability. These analyses provide novel insights
into phosphorylation-mediated regulation of Tau action upon
microtubules, functional relationships between singly andmul-
tiply phosphorylated proteins, and the plausibility of integrat-
ing aberrant phosphorylation into the misregulation of micro-
tubule dynamic instability model for Tau-mediated neuronal
cell death.
EXPERIMENTAL PROCEDURES
TauProtein Purification—Ahuman cDNAencoding the lon-
gest four-repeat Tau isoform (441 amino acids) was the starting
wild-type Tau sequence used in these studies. Specific serine/
threonine to aspartic acid amino acid substitutions to pseudo-
phosphorylate Tau were introduced into the four-repeat Tau
cDNA using the QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA). All sequences were verified by
sequence analysis prior to use (Iowa State DNA Sequencing
Facility). Recombinant Tau proteins were expressed and puri-
fied as described previously (10). Briefly, Tau expression was
induced in BL21 (DE3) cells (Novagen, Madison, WI). Bacteria
were lysed by sonication, and the lysate was clarified by centri-
fugation (12,000 g, 15min, 4 °C). Supernatants were boiled to
precipitate non-heat-stable proteins and recentrifuged. The
heat-stable proteins were adsorbed to a phosphocellulose col-
umn and eluted with a 0.2–1.0 M NaCl gradient. Fractions con-
tainingTauwere identified by SDS-PAGE followedbyCoomas-
sie Blue staining. Tau-containing fractions were pooled and
further purified by reverse-phase HPLC (DeltaPak-C18, Milli-
pore (Billerica, MA)). Tau-containing HPLC fractions were
pooled, lyophilized, and resuspended in BRB-80 buffer (80 mM
Pipes, pH 6.8, 1mM EGTA, 1mMMgSO4) with 0.1% -mercap-
toethanol. Previous work has demonstrated that Tau synthe-
sized and isolated from bacteria is unphosphorylated (63). Tau
concentrations were determined by a quantitative SDS-poly-
acrylamide gel comparison against a known “4R Tau mass
standard,” the concentration ofwhichwas established by amino
acid analysis (8). Bovine microtubule-associated protein-free
brain tubulin was prepared, and the concentrations were deter-
mined as described previously (64, 65).
Tau-Microtubule Co-sedimentation Assays—15 M micro-
tubule-associated protein-free tubulin dimer was mixed with
pseudophosphorylated 4RTau constructs at 0.25M (1:60Tau/
tubulin), 0.375M (1:40 Tau/tubulin), 0.75M (1:20 Tau/tubu-
lin), and 1.5 M (1:10 Tau/tubulin) in PEM buffer (100 mM
FIGURE 1. Construction of pseudophosphorylated 4-repeat Tau. Schematic of four-repeat Tau, with positions of pseudophosphorylated Taumarked with
arrows.Boxes labeled R1,R2,R3, andR4 correspond to the 18-amino acid imperfect repeats.Boxes labeled IR correspond to the three interrepeats. Exons 2, 3, and
10 are regulated by alternative splicing. All three exons are present in the Tau constructs used in this study.
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Pipes, pH 6.8, 1 mM MgCl2, and 1 mM EGTA) with 1 mM GTP.
Microtubules were assembled at 35 °C until steady state was
achieved (1.5 h), layered over an 80-l sucrose cushion (50%
sucrose in PEM, 2mMGTP) in 5 20-mmultraclear centrifuge
tubes (Beckman Instruments, Palo Alto, CA), and centrifuged
in a Sorvall RC70 swinging bucket rotor for 12 min at 35,000
rpm (150,000 g) at 35 °C. Supernatants and pellets were har-
vested and solubilized in SDS-PAGE sample buffer. The quan-
tity of tubulin in the supernatants and pellets were determined
by SDS-PAGE. The quantity of Tau in the supernatants and
pellets were determined by usingWestern blot analysis with the
non-phosphospecific monoclonal antibody Tau-1 (60). Values
presented in the figures and tables were corrected for a small
amount of non-Tau-dependent tubulin that pellets in control
reactions, generally in the range of 10–15% of total tubulin in
the reaction. The values represent themean S.E. from at least
three independent experiments.
Analysis of Dynamic Instability of IndividualMicrotubules by
Video Microscopy—Purified tubulin (11.7 M tubulin dimer)
was polymerized at the ends of sea urchin (Strongylocentrotus
purpuratus) axonemal seeds at 35 °C in the presence or absence
of 0.29 M purified pseudophosphorylated Tau (1:40 Tau/tu-
bulin molar ratio) in PMME buffer (87 mM Pipes, 36 mM MES,
1.4 mMMgCl2, 1 mM EDTA, pH 6.8) containing 2mMGTP and
incubated at 35 °C for 30min to achieve steady state. Time lapse
images of individual microtubules were obtained at 35 °C by
video-enhanced differential interference contrast microscopy,
as described previously (8). The number concentration of axon-
eme seeds was adjusted to 4–6 axonemes/field of view.
Dynamic instability of plus endswas analyzed once the reaction
reached steady state. Plus ends were distinguished from minus
ends on the basis of their fast growth rates, the number of
microtubules that grew at the ends, and the relative lengths of
themicrotubules (17, 30, 66). Life histories of individual micro-
tubules were collected as described (8) with modifications.
Images were collected at 1–3-s intervals. We defined microtu-
bules to be growing if they increased in length0.3mat a rate
of0.3 m/min. Shortening events were defined by a1-m
length change at a rate of 2 m/min. Microtubules that
changed 0.3 m/min over a duration of four images were
considered to be in an attenuated state. Segmentation of whole
life histories into shorter defined events was performed manu-
ally using a custom built Matlab (The MathWorks, Inc.)-based
program that determines averages, S.D. values, and S.E. values
for each parameter/condition. We next used these values to
determine the statistical confidence levels using the GraphPad
program (GraphPad Software, Inc., La Jolla, CA). Similarly, for
the detailed statistical analysis shown inTable 4 (A–G), we used
a custom built GNU Octave software (freely available on the
World Wide Web)-based program to determine the percent
confidence levels between conditions for each microtubule
dynamicity parameter. Length sequence for each event was cal-
culated by fitting a first order polynomial (i.e. a line). The slope
of each line gives the rate of the event. The length change
observed within each event was calculated with the rate multi-
plied by the duration of the event. A catastrophe was defined as
a transition from either growth or attenuation to shortening.
The catastrophe frequency was calculated as the total number
of catastrophes divided by the total time spent growing and
attenuated. A rescue was defined as a transition from shorten-
ing to either growth or attenuation. Frequencies of rescue were
calculated as the total number of rescues divided by the total
amount of time spent shortening. Average growth and shorten-
ing lengths represent the average of individual growth and
shortening events. The reported average growth and shorten-
ing rates were calculated as the total growth or shortening
length change for a particular condition divided by the total
time spent for growth or shortening events in the condition.
The percentages of time the population of microtubules spent
growing, shortening, and attenuated were determined as
described previously (67). Dynamicity is a calculated measure
of overall dynamic activity (i.e. total length grown plus total
length shortened divided by total time observed). Between 30
and 40 microtubules (with a minimum of 230 min of tracking
time for each condition) were analyzed for each experimental
condition. Each condition was imaged over multiple days using
3–5 different Tau/tubulin/GTP mixes (4–5 slides each).
RESULTS
Single and Double Pseudophosphorylation Confer Opposite
Effects upon the Ability of Four-repeat Tau to Promote Micro-
tubule Assembly—We first sought to determine whether or not
pseudophosphorylation of Tau at either one or two key known
phosphorylation sites permolecule affects its ability to promote
microtubule assembly. As a prelude, we first established the
quantitative validity of ourmicrotubule assembly assay. Briefly,
we co-incubated 15M tubulin dimers with varying amounts of
Tau (Tau/tubulin molar ratios of 1:60, 1:40, 1:20, and 1:10),
allowed microtubule assembly to proceed to completion, and
then centrifuged the assembledmicrotubules through a sucrose
cushion. These concentrations of tubulin andTau approximate
in vivo conditions (i.e. the intracellular tubulin concentration is
based on thework ofHiller andWeber (68) andZhai and Borisy
(69) and the range of Tau/tubulin ratios is based upon estimates
believed to be present in neuronal cells (70). Microtubules and
microtubule-bound Tau pelleted, whereas non-polymerized
tubulin and non-microtubule-bound Tau remained in the
supernatant on top of the cushion. Negligible amounts of tubu-
lin or Tau were present in the sucrose cushion itself. The per-
centages of Tau and tubulin in each fraction were determined
by SDS-PAGE/immunoblotting analysis of the pellet and
supernatant. As seen in Fig. 2, increased amounts of Tau in the
reaction resulted in increasedmicrotubule assembly. The spec-
ificity of the reaction is demonstrated by the lack of any increase
in microtubule assembly when Tau was replaced by the non-
specific protein BSA.
We next sought to determine if pseudophosphorylation of
Tau at one or two key sites affects its ability to promote micro-
tubule assembly. First, we assayed Tau pseudophosphorylated
at only one site per molecule (i.e. either T231D, S262D, S396D,
or S404D). These are all believed to be important sites of Tau
phosphorylation (for more details, see “Discussion”). In all four
cases, singly pseudophosphorylated Tau promoted less micro-
tubule assembly than control, non-pseudophosphorylated Tau
(referred to asWT in the figures), most significantly in the cases
of S262D and S396D (Fig. 3A and Table 1). Additionally, as
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expected, the quantity of microtubule assembly increased with
increasing Tau concentration in all cases.
We next compared the microtubule assembly activities of
doubly pseudophosphorylated four-repeat Tau with those of
their singly pseudophosphorylated counterparts and control,
non-pseudophosphorylated Tau. Based on the observation that
all singly pseudophosphorylated Tau molecules exhibited
reduced microtubule assembly activities relative to control,
non-pseudophosphorylatedTau, the simplest prediction is that
doubly pseudophosphorylated Tau should be even further
compromised. Inmarked contrast, three of the four tested dou-
bly pseudophosphorylated Tau molecules (T231D/S262D,
S262D/S396D, and S262D/S404D) exhibited greater microtu-
bule assembly-promoting activity than control, non-pseudo-
phosphorylated Tau (Fig. 3A and Table 1). The fourth doubly
pseudophosphorylated construct, S396D/S404D, exhibited
complex microtubule assembly activity, possessing increased
potency at lower concentrations and reduced potency at higher
concentrations. Taken together, the simple prediction that
multiple pseudophosphorylation events would be additive and
further reduce microtubule assembly activity below that of the
individual pseudophosphorylation events was not fulfilled.
Rather, the data demonstrate that the combinatorial effect of
two pseudophosphorylation events need not be the additive
effects of the two individual events. Indeed, double pseudo-
phosphorylation events generally enhanced microtubule
assembly activity even beyond the level of control, non-pseudo-
phosphorylated Tau, whereas single pseudophosphorylation at
each of the sites tested suppressed Tau-mediated microtubule
assembly activity.
In order to better understand mechanisms underlying these
observations, we next examined the quantity of Tau bound to
the pelletedmicrotubules in each assembly reaction. As seen in
Table 2, essentially all of the control, non-pseudophosphory-
lated Tau was bound to the microtubules at all concentrations
tested. In contrast, all of the singly pseudophosphorylated Tau
molecules were, to varying extents, less effective at interacting
withmicrotubules. Interestingly, as the concentration of Tau in
the S262D and S404D reactions increased, the percentage of
bound Tau decreased, perhaps suggesting a saturation effect
that was not observed over the same concentration range for
control, non-pseudophosphorylated Tau. Alternatively, it is
possible that S262D and S404D could be aggregating. However,
we believe that this is unlikely because (i) recombinant Tau,
even mutants that are strong aggregators, does not aggregate
under physiological in vitro conditions without the addition of
an inducer, such as arachidonic acid (71, 72), and (ii) we have
performed direct aggregation studies (using dynamic light scat-
tering) on all of the pseudophosphorylatedTau proteins used in
this study, and none aggregate in the absence of an inducer.3
Similar analysis of Tau levels present in the microtubules
assembled by the doubly pseudophosphorylated Taumolecules
revealed a different situation (Table 2). Two of the molecules,
S262D/S396D and S262D/S404D, showed no difference at all
relative to control, non-pseudophosphorylated Tau despite the
fact that the microtubule assembly activities of singly pseudo-
phosphorylated S262DandS404Dwere strongly compromised.
The remaining two doubly pseudophosphorylated molecules,
T231D/S262D and S396D/S404D, bound only slightly less well
than control, non-pseudophosphorylated Tau. Taken together,
and as was true for the tubulin analysis shown in Fig. 3A, the
combined effects of two phosphorylation events within a single
Tau molecule can be very different from the sum of the effects
of the two constituent events when present in individual
molecules.
As a finalmeasure of the ability of different Tau constructs to
promote microtubule assembly, we used the data in Tables 1
and 2 to calculate the tubulin/Tau “packing” ratio in the assem-
bled microtubules for each reaction (Fig. 3B). At the lowest
tested Tau/tubulin ratio used in the initial reaction mixtures
(1:60; 0.25 M Tau), control, non-pseudophosphorylated Tau
assembles microtubules composed of28 tubulin dimers/Tau
molecule. Under similar conditions, all four of the singly pseu-
dophosphorylated Tau constructs were less effective, assem-
bling between 8 and 20 tubulin dimers/Tau. In marked con-
trast, all four of the doubly pseudophosphorylated Tau
constructs were much more effective than even control, non-
pseudophosphorylated Tau, assembling microtubules with
between 36 and 45 tubulin dimers/Tau, consistent with their
increased ability to promotemicrotubule assembly (Table 1 and
Fig. 3A). As the concentration of Tau increased in the reactions,
the differences between the different Tau constructs decreased.
At the highest concentration of Tau (1:10Tau/tubulin ratio), all
of the reactions converged on a tubulin/Tau ratio in assembled
microtubules of12.
Taken together, the data are consistent with the conclusion
that the effects of double pseudophosphorylation of Tau at
positions Thr231, Ser262, Ser396, and/or Ser404 uponMT assem-
bly activity are not simply the sum of the parts. Indeed, in
almost all cases, the effects of doubly pseudophosphorylated
Tau molecules are opposite to the effects of the same pseudo-
phosphorylation events in a singly pseudophosphorylated con-
3 E. Kiris, D. Ventimiglia, and S. C. Feinstein, unpublished data.
FIGURE 2. Tau-microtubule co-sedimentation assay. 15M tubulin dimers
were incubated in thepresenceor absenceof varying amounts of four-repeat
Tau or the nonspecific protein BSA at 35 °C until steady state was achieved.
The reaction was then centrifuged through a sucrose cushion. Microtubules
and microtubule-bound Tau pellet, whereas non-polymerized tubulin and
non-microtubule-bound Tau remain in the supernatant. SDS-PAGE analysis
of the supernatant and pellet defines the percentages of tubulin in each frac-
tion. The percentage of polymerized tubulin values are presented asmean
S.E. (error bars).
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text. It is also interesting to note the general clustering of activ-
ities of the four singly pseudophosphorylated Tau proteins
and the four doubly pseudophosphorylated Tau proteins
despite the different locations of their pseudophosphoryla-
tion mutations.
Doubly Pseudophosphorylated Tau Proteins Regulate Micro-
tubule Dynamic Instability Much Differently than the Sum of
the Effects of the Two Constituent Singly Pseudophosphorylated
Tau Proteins—“Dynamic instability” is the term used to
describe the dynamic behavior ofmicrotubules inwhichmicro-
tubule ends switch between phases of relatively slow growth
and rapid shortening, interspersed with periods of pause or
“attenuation.” As noted above, proper regulation of microtu-
bule dynamic instability is critical for proper cell function and
viability (16, 21, 22).
As another assessment of the effects of single and double
pseudophosphorylation upon Tau action, we examined the
abilities of our pseudophosphorylated Tau proteins to regulate
the dynamic instability behavior at the plus end of individual
microtubules in vitro at steady state. Examples of the life history
plots of changes in length of individual microtubules versus
time are shown in Fig. 4. Because our studies were performed at
steady state (i.e. when microtubule mass and soluble tubulin
concentrations were not changing), we could observe all three
FIGURE 3. Effects of single anddouble pseudophosphorylationupon the ability of Tau topromotemicrotubule assembly.A, 15M tubulin dimerswere
incubated in the presence or absence of varying amounts of four-repeat Tau at 35 °C until steady state was achieved. The reaction was then centrifuged
througha sucrose cushion.Microtubules andmicrotubule-boundTaupellet,whereas non-microtubule boundTau andnon-polymerized tubulin remain in the
supernatant. SDS-PAGE analysis of the supernatant and pellet defines the percentages of tubulin in each fraction. Statistical significance of the data based on
Student’s t test is presented in Table 1. B, effects of Tau pseudophosphorylation on the tubulin/Tau “packing ratio” in assembledmicrotubules. Data for tubulin
andTau content in assembledmicrotubules are fromFig. 3A andTables 1 and2. The values are given asmean S.E. (error bars) fromat least three independent
experiments.
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phases of dynamic instability (growth, shortening, and attenu-
ation). The following parameters were determined: (i) average
shortening rate; (ii) average length shortened per shortening
event; (iii) average growth rate; (iv) average length grown per
growth event; (v) percentage of time spent growing, shortening,
and attenuated; (vi) rescue frequency; (vii) catastrophe frequen-
cy; and (viii) overall dynamicity. The data (described below) are
presented graphically in Figs. 5–8 and are summarized quanti-
tatively in Table 3. Comparative statistical analyses of the data
are presented in Table 4 (A–G).
Shortening Events—The ability of 4R Tau to suppress the
average shortening rate was markedly reduced for two singly
pseudophosphorylated Tau constructs, S262D and S396D. On
the other hand, relative to control, non-pseudophosphorylated
Tau, the shortening rate for T231D was unaffected, and it was
slightly increased for Ser404 (Fig. 5A and Table 3). In contrast,
all four doubly pseudophosphorylated Tau constructs exhib-
ited either control, non-pseudophosphorylated Tau levels of
activity (T231D/S262D and S262D/S396D) or significantly
enhanced activity (S262D/S404DandS396D/S404D) relative to
control Tau. A particularly glaring example of the lack of simple
additivity of single and double pseudophosphorylation is to
compare S262D and S396D as singly pseudophosphorylated
constructs (both severely compromised relative to control Tau)
and as a doubly pseudophosphorylated construct (S262/S396D;
no loss-of-function at all relative to control, non-pseudophos-
phorylated Tau).
The ability of control Tau to reduce the average lengths of
shortening events was reduced strongly for three of the singly
pseudophosphorylated Tau constructs (T231D, S262D, and
S396D; Fig. 5A and Table 3). S404D also exhibited reduced
ability to regulate the average length of shortening events, but
the effectwasweaker than for theother singlypseudophosphor-
ylatedTau proteins. Similarly, all four doubly pseudophosphor-
ylated Tau constructs exhibited compromised Tau-mediated
reduction in the average length of shortening events; however,
the magnitude of the effects was less than was the case for the
singly pseudophosphorylatedTau constructs. Again, the effects
of single pseudophosphorylation events are not additive when
the constituent pseudophosphorylation events are combined in
doubly pseudophosphorylated Tau molecules.
Growth Events—The ability of three of the four singly pseu-
dophosphorylated Tau constructs to suppress the average
growth rate was somewhat compromised relative to control
Tau (T231D, S262D, and S404D), whereas S396D was not
affected significantly (Fig. 5B and Table 3). In contrast,
although three of the four doubly pseudophosphorylated Tau
constructs were unaffected relative to control Tau, S396D/
S404D was very significantly compromised in its ability to reg-
ulate the rate of growth events.
Normal Tau exerts only a relatively modest effect on the
length of MT growth events. Therefore, it was not surprising
that the average growth length during individual growth events
for singly and doubly pseudophosphorylated Tau constructs
TABLE 1
Dose-response analysis of pseudophosphorylated Tau-mediated microtubule assembly
Percentage of polymerized tubulin values are given as mean S.E.
Constructs
Percentage of tubulin in pellet
1:60 Tau/tubulin ratio
(0.25 M Tau)
1:40 Tau/tubulin ratio
(0.375 M Tau)
1:20 Tau/tubulin ratio
(0.75 M Tau)
1:10 Tau/tubulin ratio
(1.5 M Tau)
% % % %
4RWT 43 1.31 62 2.89 92 1.23 100 0.07
4R T231D 28 5.91a 50 6.80 68 2.85b 93 0.75c
4R S262D 14 1.14a 34 3.37d 53 6.85b 71 5.18c
4R S396D 17 2.12a 40 1.05d 70 4.02d 87 0.40c
4R S404D 25 5.68a 45 3.02d 67 2.92 83 2.80c
4R T231D/S262D 57 3.21a 72 1.93 92 2.12 100 0.0
4R S262D/S396D 63 2.50a 81 1.68d 100 0.0 100 0.0
4R S262D/S404D 68 4.23a 76 1.66e 96 0.47 100 0.0
4R S396D/S404D 53 1.0a 66 2.0 80 0.58 89 0.88c
a Values significant at 99.9% confidence level compared with WT control at a 1:60 Tau/tubulin dimer ratio.
b Values significant at 99.9% confidence level compared with WT control at a 1:20 Tau/tubulin dimer ratio.
c Values significant at 99.9% confidence level compared with WT control at a 1:10 Tau/tubulin dimer ratio.
d Values significant at 99.9% confidence level compared with WT control at a 1:40 Tau/tubulin dimer ratio.
e Value significant at 95% confidence level compared with WT control at a 1:40 Tau/tubulin dimer ratio.
TABLE 2
Effects of Tau pseudophosphorylation on Tau-microtubule interaction
Percentage of bound Tau values are given as mean S.E.
Constructs
Percentage of Tau in pellet
1:60 Tau/tubulin ratio
(0.25 M Tau)
1:40 Tau/tubulin ratio
(0.375 M Tau)
1:20 Tau/tubulin ratio
(0.75 M Tau)
1:10 Tau/tubulin ratio
(1.5 M Tau)
% % % %
4RWT 93 1.49 95 1.19 98 0.90 97 1.60
4R T231D 83 9.29 81 9.24 83 1.76 87 3.84
4R S262D 89 2.76 83 2.77 79 1.97 72 3.61
4R S396D 94 1.86 91 1.76 86 5.40 88 5.19
4R S404D 92 5.10 85 4.50 76 4.67 73 8.11
4R T231D/S262D 93 3.93 87 4.04 90 5.20 89 4.00
4R S262D/S396D 93 1.15 98 1.67 99 0.67 100 0.0
4R S262D/S404D 93 2.85 97 1.53 100 0.33 100 0.0
4R S396D/S404D 89 2.33 87 3.18 81 3.18 81 0.0
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was not affectedmuch (Fig. 5B and Table 3), with the exception
of S262D/R404D, which suppressed the average length of
growth events slightly more potently than did control Tau.
Catastrophe and Rescue Frequencies—A catastrophe is
defined as the conversion of a growth or attenuation event to a
shortening event. Control, non-pseudophosphorylated Tau
greatly decreases the catastrophe frequency (Fig. 6A and Table
3). All four singly pseudophosphorylated Tau constructs, espe-
cially T231D and S262D, exhibit much less ability to prevent
catastrophes than does control, non-pseudophosphorylated
Tau. In contrast, all four doubly pseudophosphorylated Tau
proteins exhibit greater catastrophe-preventing activity than
their singly pseudophosphorylated counterparts, with two of
the doubly pseudophosphorylated Tau proteins (S262D/S396D
and S262D/S404D) exhibiting near control Tau levels of activ-
ity. Again, doubly pseudophosphorylated Tau molecules
exhibit less, notmore, loss of function than do their singly pseu-
dophosphorylated counterparts. Additionally, it is notable that
all four singly pseudophosphorylatedTauproteins exhibit quite
similar levels of activity with one another, as do the four doubly
pseudophosphorylated Tau proteins.
A rescue event is defined as conversion of a shortening event
to either attenuation or growth. Control, non-pseudophosphor-
ylated Tau significantly increases the rescue frequency (Fig. 6B
and Table 3). In contrast, all of the singly and doubly pseudo-
phosphorylated Tau constructs are defective in promoting res-
cue events.
Percentage of Time in Each Phase—As seen in Fig. 7 and
Table 3, in the absence of Tau, the microtubules used in this
work spend 51% of their time attenuated, 35% of their time
growing, and 14% of their time shortening. The presence of
control, non-pseudophosphorylated Tau increased the per-
centage of time attenuated, reduced the percentage of time
growing, and almost eliminated time shortening. All four of the
singly pseudophosphorylated Tau molecules were compro-
mised in their abilities to influence the percentage of time
microtubules are in growth, shortening, or attenuated phases.
In contrast, all four doubly pseudophosphorylated Tau con-
structs exhibit near control Tau percentages. This provides yet
another example of the doubly pseudophosphorylated con-
structs not exhibiting the predicted effects of a simple additive
model for combinatorial pseudophosphorylation.
Dynamicity—Dynamicity is a calculated measure of overall
dynamic activity (i.e. total length grown plus total length short-
ened divided by total time observed). Control Tau reduces
microtubule dynamicity by over 5-fold (Fig. 8 and Table 3). All
four singly pseudophosphorylated Tau constructs suppressed
dynamicitymuch less effectively than did control, non-pseudo-
phosphorylated Tau. In contrast, one of the four doubly pseu-
dophosphorylated Tau proteins exhibited dynamicity-sup-
pressing activity that was very similar to that of control Tau,
whereas the other three remained compromised but to a lesser
extent than their singly pseudophosphorylated counterparts.
DISCUSSSION
Among the primary goals of the work presented here was to
better understand molecular mechanisms by which phosphor-
ylation regulates Tau-mediated action, focusing on microtu-
bule assembly and the regulation ofmicrotubule dynamic insta-
bility. Importantly, we sought to begin investigating the
mechanistic effects of combinatorial Tau phosphorylation,
which is of certain in vivo relevance yet remains an almost com-
pletely unstudied question. Further, understanding basic prin-
ciples of combinatorial phosphorylation as a regulatory mech-
FIGURE 4. Examples of microtubule life history plots. Changes in the
length of themicrotubules grown in the absence of Tau (top), in the presence
of 0.293 M 4R WT Tau (1:40 Tau/tubulin dimer ratio;middle), or in the pres-
ence of 0.293 M 4R S262D pseudophosphorylated Tau (1:40 Tau/tubulin
dimer ratio; bottom) were plotted as a function of time. From these and addi-
tional life historyplots, individual growth, shortening, andattenuationevents
were identified, and rates and lengths of each event were determined, as
described under “Experimental Procedures.”
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anism is a critically important general question far beyond just
Tau and microtubules.
In the simplest case, one could imagine that multiple phos-
phorylation events located in functionally and physically dis-
tinct regions of a protein could act completely independently of
one another. For example, one phosphorylation event might
regulate an SH2 domain interaction, and another event located
elsewhere in the protein might regulate some local conforma-
tional change. There are many such examples (e.g. the Src
kinase) (73). On the other hand, one could also imagine that
multiple phosphorylation events on a single protein molecule
could cause integrated structural effects such that the overall
mechanistic effect is different from the sum of the parts.
The first and most important outcome of this work was that
the activities exhibited by Tau molecules harboring pseudo-
phosphorylation at two sites per molecule were not simply the
sum of the activities of the constituent two Tau molecules har-
boring the corresponding individual pseudophosphorylations.
In fact, no clear cases of simple additivity were observed (i.e.
therewere no cases inwhich both singly pseudophosphorylated
Tau proteins exhibited loss-of-function effects and the doubly
pseudophosphorylated protein exhibited a larger loss-of-func-
tion effect). Rather, we observed (i) several cases in which the
doubly pseudophosphorylated Tau protein exhibited an oppo-
site effect from that exhibited by its singly pseudophosphory-
lated counterparts (such asT231D/S262D (microtubule assem-
bly reactions, shortening length, and catastrophe frequency),
S262D/S396D (microtubule assembly reactions, shortening
length, and catastrophe frequency), and S262D/S404D (micro-
tubule assembly reactions and catastrophe frequency)) and (ii)
several cases in which the two singly pseudophosphorylated
Tau proteins exhibited quite different activity levels from one
another and the doubly pseudophosphorylated protein closely
resembled the activity level of one but not the other of the
constituent singly pseudophosphorylatedTau proteins (such as
T231D/S262D (shortening rate), S262D/S404D (shortening
rate and shortening length), and S396D/S404D (shortening
rate, shortening length, and growth rate)). Interestingly, among
the doubly pseudophosphorylated Tau proteins in this latter
class, position Ser404 appears to be dominant (i.e. the doubly
pseudophosphorylated Tau protein exhibits the activity level of
the singly pseudophosphorylated Ser404 Tau protein rather
than that of the second pseudophosphorylated site). In con-
trast, pseudophosphorylation at position Ser262 or Ser396 does
not exert such a “dominant” effect in any of the doubly pseudo-
phosphorylated Tau proteins. Finally, there were several cases
in which the two singly pseudophosphorylated Tau proteins
exhibited similar levels of an activity and the doubly pseudo-
FIGURE 5. Effects of various single and double pseudophosphorylation uponmicrotubule shortening (A) and growth (B) events. The positions of the
ends of individual microtubules were tracked in the presence or absence ofWT or pseudophosphorylated Tau at a 1:40molar ratio of Tau/tubulin dimers, and
life history plots were generated. From these data, individual growth, shortening, and attenuation events were identified. A, the average growth and short-
ening rates were calculated as the total growth or shortening length change for a particular reaction condition divided by the total time spent for growth or
shortening events in that condition. Average growth and shortening lengths represent the average of independent growth and shortening events. Values are
given as mean S.E. (error bars). n values for each condition are presented in Table 3. *, value significant at 95% confidence level compared with 4R WT Tau
control conditions. **, value significant at 99.9% confidence level compared with 4R WT Tau control conditions.
TABLE 3
Effects of the pseudophosphorylation events upon themicrotubule dynamicity parameters at steady state in vitro
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TABLE 4
Percent statistical confidence levels between conditions for each microtubule dynamicity parameter
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phosphorylated Tau protein also exhibited a similar (but not
additive) activity level.
Another unexpected and striking effect was the lack of wide-
spread site-specific effects of single pseudophosphorylation
events on the ability of Tau to regulate microtubule dynamics
(i.e. the relatively high frequency with which different pseudo-
phosphorylated Tau proteins exhibit very similar levels of an
activity that differ from the activity level of control Tau). One
might anticipate that different sites of pseudophosphorylation
would exert very different effects on different parameters of
microtubule dynamics. However, little site specificity was
observed. Indeed, the only clear cases in which different singly
pseudophosphorylated Tau proteins differentially affected
microtubule dynamics markedly were in the regulation of
shortening events. For example, pseudophosphorylation of Tau
at positions 262 and 396 greatly compromised the ability of Tau
to suppress the rate of microtubule-shortening events, whereas
pseudophosphorylation of Tau at either 231 or 404 had little
effect. Similarly, pseudophosphorylation of Tau at 231, 262, or
396 greatly compromised its ability to reduce the average length
of shortening events, whereas pseudophosphorylation of Tau at
404 had little effect. However, by all other parameters of micro-
tubule dynamics, the loss-of-function effects resulting from
pseudophosphorylation were similar for the four different sin-
gly pseudophosphorylated Tau proteins despite having their
pseudophosphates at different locations. The similarity of
activity levels among Tau proteins harboring different sites of
pseudophosphorylationwas evenmore pronounced among the
doubly pseudophosphorylated Tau proteins. For example, Tau
pseudophosphorylated at Thr231/Ser262 showed very similar
activity levels to Tau pseudophosphorylated at Ser262/Ser396 by
all of ourmany assays. An evenmore remarkable case is the fact
that Tau pseudophosphorylated at Thr231/Ser262 is very similar
to Tau pseudophosphorylated at Ser396/Ser404 in numerous
TABLE 4—continued
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assays (shortening rate, growth length, rescue frequency, and
catastrophe frequency), despite having no pseudophosphoryla-
tion sites in common.Many other examples of different doubly
pseudophosphorylated Tau molecules acting similarly by 3–4
criteria can be identified (see Fig. 5–8 and Table 4).
Phosphorylation Regulates the Ability of Tau to Regulate
MicrotubuleAssembly—Previouswork, both in vitro and in cul-
tured cells, has led to the conclusion that phosphorylation of
Tau at a large number of individual sites reduces microtubule
binding and assembly activities (74–81). Our analysis of Tau
proteins harboring single pseudophosphorylation events at
positions Thr231, Ser262, Ser396, and Ser404 are consistent with
these conclusions (i.e. all exhibit reduced levels of microtubule
assembly activity). It is therefore all the more remarkable to
note that, at all Tau/tubulin ratios short of saturation, all doubly
pseudophosphorylated Tau proteins promoted microtubule
assemblymore effectively than either singly pseudophosphory-
lated Tau or control, non-pseudophosphorylated Tau, despite
their reduced Tau/tubulin packing ratios. This increased
potency of the doubly pseudophosphorylated Tau is apparent
from both the tubulin assembly data in Fig. 3A and the tubulin/
Tau packing ratio data in Fig. 3B. These data clearly demon-
strate the inadequacy of the simple additivity mechanism for
combinatorial phosphorylation-mediated regulation of Tau
action.
Phosphorylation Regulates the Ability of Tau to Regulate
Microtubule Dynamic Instability—In contrast to the abun-
dance of previous work on the effects of Tau phosphorylation
upon its ability to bind to microtubules and to promote micro-
tubule assembly, there has been much less work examining the
effects of phosphorylation upon the ability of Tau to regulate
microtubule dynamic instability. Drechsel et al. (15) examined
the effects of MAP2 kinase on the ability of Tau to regulate
microtubule dynamic instability in vitro under non-steady state
conditions, observing an increased rate of microtubule growth,
a decreased rate of shortening, and decreased catastrophe fre-
quency. However, the extent of phosphorylation and site(s) of
phosphorylationwere not determined. Trinczek et al. (9) exam-
ined the effects of CDK5 and MARK kinase activities upon the
ability of Tau to regulate microtubule dynamic instability in
vitro (9), also under non-steady state conditions. Phosphoryla-
tion of Tau by CDK5, which phosphorylated Ser202, Ser235, and
Ser404 to undetermined extents, increased the catastrophe fre-
quency 4-fold compared with control, non-phosphorylated
Tau. Phosphorylation of Tau by MARK (mainly at Ser262 but
perhaps also Ser356) increased the catastrophe frequency quite
significantly, thereby increasing the dynamicity about 40-fold
compared with control Tau. It is important to note that both
the Drechsel et al. (15) and Trinczek et al. (9) studies were
performed at non-steady state conditions (which is probably a
better approximation of conditions in a developing rather than
a mature neuron) and at extraordinarily high Tau/tubulin
ratios, in marked contrast to our work.
In the work presented here, we show that pseudophosphory-
lation of Tau at defined single sites (Thr231, Ser262, Ser396, or
Ser404) can modulate its ability to regulate microtubule
dynamic instability (Figs. 5–8 and Table 3). The most marked
effects are on shortening events (shortening rate, average
length of shortening events, and rescue frequency) as well as
the percentage of time in different phases. Further, the data are
consistent with themicrotubule assembly data described above
in that they do not support the simple additivity view of com-
binatorial Tau phosphorylation effects on Tau action.
ANovel View of Combinatorial Tau Phosphorylation—Given
that there are30 known phosphorylation sites on Tau (43, 82,
83), regulation of Tau activity via phosphorylation has often
been compared with a rheostat as opposed to a series of toggle
switches, suggesting that the many different phosphorylation
sites each confer different structural and functional effects
along a gradient of activity levels. This analogy would predict
that there should be significant activity differences among the
four different singly pseudophosphorylated constructs and the
four different doubly pseudophosphorylated constructs. How-
ever, as noted above, this was not generally observed. Given
these observations, perhaps both the rheostat and toggle switch
analogies require revisiting. As an alternative, perhaps there are
only a small number of different structure-function states of
Tau, but these states need to be tightly regulated by a large
number of different signaling pathways. In its simplest form,
perhaps one phosphate located at any of a number of sites con-
FIGURE 6. Effects of various single and double pseudophosphorylation upon catastrophe (A) and rescue (B) frequencies. A catastrophe is defined as
conversion of a growing or attenuation event to a shortening event. Catastrophe frequencies were calculated as the total number of catastrophes divided by
the total time spent growing and attenuated. A rescue is defined as a transition from shortening to either growth or attenuation. Rescue frequencies were
calculatedas the total numberof rescuesdividedby the total amountof time spent shortening. Basedupon the life historyplots described in Fig. 4, catastrophe
and rescue frequencies were calculated. Values are given as mean S.E. (error bars). *, value significant at 95% confidence level compared with 4R WT Tau
control conditions. **, values significant at 99.9% confidence level compared with 4R WT Tau control conditions.
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fers structure-function state “A”, whereas two phosphates
located at any of a number of different possible locations on a
Tau molecule confer structure-function state “B”. Thus, it
could be that the primary mechanistic effects of phosphoryla-
tion are determined by the number of phosphates permolecule,
with more subtle modulatory effects mediated in a site-specific
manner. By this perspective, the large number of phosphorylat-
able sites in Tau could be a consequence of the many signaling
pathways regulating Tau activity (and the sequence-specific
substrate requirements of their many kinases) rather than a
large number of structure-function states. This is certainly a
testable hypothesis.
Statistical analyses also highlighted the fact that the activities
of many doubly pseudophosphorylated Tau molecules closely
resemble those of control Tau. Speculatively, this could provide
a kind of molecular “history” or “memory” by which compara-
ble levels of activity can be achieved in differently phosphory-
lated Tau molecules, which could be regulated differentially by
subsequent effectors or circumstances.
Phosphorylation and Pathological Tau Action—A large body
of biochemical and genetic data supports the conclusion that
aberrant regulation of Tau phosphorylation can cause neuro-
degeneration (5, 6). Unfortunately, the underlying mecha-
nism(s) remains elusive. One widely held model suggests that
abnormal Tau phosphorylation increases the probability that
Tau will oligomerize and then aggregate and that either one or
both of these conditions is cytotoxic. Alternatively, integrating
work in dividing cells with our recent in vitro (8, 21, 22, 30, 60)
and cell culture work (10, 61), we and our collaborators have
hypothesized that Tau-mediated neuronal cell death in the
Tauopathies might be caused, at least in part, by aberrant Tau-
mediated regulation of microtubule dynamic instability. In the
original presentations of this hypothesis, the emphasis was
upon errors in Tau action caused by mutations (61, 62). Here,
with the confirmation of the fact that Tau phosphorylation can
alter the regulation of microtubule dynamic instability, we can
expand the earlier hypothesis to propose that errors in Tau
action, caused by either mutations or aberrant phosphoryla-
tion, can induce neuronal cell death and dementia.
Technical Issues; Choice of Sites to Investigate, Concerns with
Taxol, and Pseudophosphorylation as a Strategy—Three tech-
nical issues regarding the relatively large literature regarding
Tau action and phosphorylation are especially worthy of note.
First, we have focused our efforts on four particularly important
Tau phosphorylation sites (Fig. 1). Thr231 lies in the proline-
rich regulatory region of Tau, and phosphorylation of this site is
essential for prolyl isomerase Pin1 activity, which catalyzes the
cis/trans isomerization of the Thr231-Pro232 bond and is critical
for neuronal function (76, 84). Ser262maps to the first imperfect
repeat. The role of Ser262 phosphorylation in Tau action is con-
troversial, with some investigators observing dramatic effects
upon the microtubule binding activity of Tau, whereas others
observe more muted effects (78, 79, 81). Both Ser396 and Ser404
map to the regulatoryC-terminal tail. It has been suggested that
the FTDP-17 R406W mutation might cause disease indirectly
by altering the ability of nearby serines (including Ser396, Ser400,
and Ser404) to act as kinase substrates (61, 85). Further, Thr231,
Ser262, Ser396, and Ser404 are all consistently hyperphosphory-
lated in neurofibrillary tangles andwidely believed to be impor-
tant players in pathological Tau action (42, 43). Finally, it is
important to note that essentially nothing is known about the
combinatorial pattern of Tau phosphorylation under either
normal or pathological conditions. The combinations used
here may or may not exist in vivo; they have been selected for
analysis based primarily upon the importance of the individual
sites and placed in the same protein to assess their combinato-
rial effects.
Second, many previous studies have assessed the effects of
site-specific phosphorylation upon the ability of Tau to bind to
taxol-stabilized microtubules in vitro. However, taxol binds
very close to one of two Tau binding sites onmicrotubules (86),
raising the possibility that the presence of taxol might affect
Tau binding to microtubules. Indeed, studies from others and
from our laboratory show that taxol reduces Tau binding to
FIGURE 7. Effects of various single and double pseudophosphorylation
upontotal timespent forattenuation,growth,or shortening.Basedupon
the life history plots described in Fig. 4, the percentage of time spent in each
phase was calculated.
FIGURE 8. Effects of various single and double pseudophosphorylation
upon overall microtubule dynamics at steady state in vitro.Dynamicity is
a calculated measure of overall dynamic activity (i.e. total length grown plus
total length shortened divided by total time observed). Based upon the life
history plots described in Fig. 4, dynamicity was calculated for all conditions.
Values are given as mean S.E. (error bars). *, value significant at 95% confi-
dence level compared with 4R WT Tau control conditions. **, values signifi-
cant at 99.9% confidence level compared with 4RWT Tau control conditions.
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microtubules (86–88). To avoid this complication, the work in
this paper has assayed Tau activities in the absence of taxol.
Finally, a brief comment is warranted regarding themeans of
generating phosphorylated Tau proteins for analysis. In most
earlier studies, this has been achieved with purified kinases.
However, generating Tau proteins with site-specific phosphor-
ylation using kinases in vitro can be problematic because (i)
kinases generally phosphorylate Tau at multiple sites, and (ii)
the efficiency of phosphorylation reactions at any given site can
be low and difficult to control. These issues can greatly compli-
cate data analysis and interpretation. To avoid these problems,
we have employed “pseudophosphorylation” (i.e. the substitu-
tion of aspartic or glutamic acid residues to mimic phosphory-
lated amino acids). The major advantages of this widely used
strategy over enzymatically phosphorylating a protein with a
particular kinase are (i) “phosphorylation” at the site of interest
is 100% efficient, and (ii) there is no phosphorylation at unin-
tended sites to complicate data interpretation (51, 89–92). The
main caveat of pseudophosphorylation is that it does not pre-
cisely mimic the chemistry of a phosphate group. Nonetheless,
pseudophosphorylation has been widely and successfully used
in vitro and in cultured cells to assess various aspects of phos-
phorylation-mediated events, including the regulation of nor-
mal and pathological Tau action (51, 92–96). Thus, although
some differencesmay be found between themechanistic effects
of phosphorylated Tau versus that of pseudophosphorylated
Tau, precedent suggests that pseudophosphorylation provides
a reasonable prediction of how site-specific phosphorylation
will affect Tau function.
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